Medical cannabis and its effect on oncological outcomes in patients with ovarian cancer treated with PARP inhibitors.

Shira Peleg HassonEliya ShacharMiriam R BrezisAkram SaadBar ToledanoNadav MichaanIdo LaskovDan GrisaruJeffrey GoldsteinAmir NutmanTamar Safra

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)

Medical cannabis usage in patients receiving PARPi treatment showed no association with duration of PARPi therapy, progression-free survival, or overall survival.

Keyphrases

free survival
healthcare
dna damage
rectal cancer
prostate cancer
radical prostatectomy
robot assisted
metabolic syndrome
adipose tissue
replacement therapy
skeletal muscle